Case 3: Leaving Coronary Revascularization Options Open: Hybrid DES/DCB in an LAD

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Cordis Corporation, a Johnson & Johnson company</li></ul>